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Summary
This meta-analysis reviewed published literature comparing human male and female umbilical cord total testosterone (T) levels. Eighteen studies using 1229 samples from 602 male and 627 female newborns were analyzed using the RevMan 5 statistical package. Analysis using the inverse variance method based on a random-effects model revealed significantly higher cord T in boys than girls at a moderate effect size (Hedges' g = 0.57). There was significant heterogeneity between the 18 studies, though the five studies using direct assays showed no heterogeneity. For studies using extraction and chromatography, those that combined T from arterial and
Introduction
Barker (2004) proposed that some diseases of adulthood may have their origin in conditions in the fetal environment, and that low birth weight is associated with insulin resistance, type 2 diabetes, hypertension, and coronary heart diseases in adults. This hypothesis is supported by research showing that elevated maternal testosterone (T) is related to low birth weight in sheep (Manikkam et al., 2006) and humans (Carlsen et al., 2006) . Elevated maternal T in rhesus monkeys in late pregnancy causes hyperinsulinemia, and in early pregnancy additionally causes type II diabetes (Abbott et al., 2009 ).
Elevated maternal T in either early or late gestation doubles the risk of the female offspring of rhesus monkeys suffering from anovulation and polycystic ovaries in adulthood (Resko et al., 1987) . Animal research suggests that females may be more sensitive to the effects of T on brain development than males (Roselli et al., 2007) so it is especially important to assess potential risks to the female fetus of exposure to T. However at present there is no definitive consensus as to whether T is normally lower at birth in the umbilical cord of healthy human females pregnancies than in male, so it has been difficult to make clinical judgements regarding prenatal risk of T exposure based on levels of umbilical cord T. It is hoped that the identification of normative sex differences in T levels in the present meta-analysis will contribute to our scientific and clinical understanding of this issue.
Polycystic ovary syndrome (PCOS) affects 5-10% of women (Franks, 1995) and is hypothesised to develop as a result of exposure to elevated T prenatally (Dumesic et al., 2006) . Some recent research suggests that umbilical vein T is elevated in female newborns of mothers with PCOS (Barry et al., 2010) . Placental aromatase is traditionally thought to protect the fetus from raised maternal T, but animal research contradicts this hypothesis (Resko et al., 1987; Manikkam et al., 2006; Abbott et al., 2009) .
To date, studies have produced mixed evidence regarding a sex difference in umbilical vein T. Some studies have found that compared to female newborns, male newborns have more umbilical vein T (Herruzo et al., 1993) , less (Pardo et al., 1993) , or virtually identical levels (van de Beek et al., 2004) . Establishing a norm for umbilical cord T is difficult because the commonly used 'direct' assay methods (described in discussion section, below) lack the sensitivity to accurately detect T at levels below 10 nmol/l (Rosner et al., 2007) ; although umbilical vein T tends to be higher than circulating T in women of reproductive age (Baik et al., 2004) it is usually below the 10 nmol/l detection threshold suggested for direct assays (see Table II ).
Fetal T can be measured from various sites. Although amniotic fluid is the best candidate to investigate the effects of early fetal androgen exposure (van de Beek et al., 2004) , it is not comparable to cord T at the end of gestation because amniotic T is sampled around weeks 11 to 21 when a sex difference in T is likely to largest because of the testosterone surge in male fetuses (Smail et al., 1981) . Most studies of fetal T sample from the umbilical vein at birth; fewer studies sample mixed (arteries + vein) cord blood, and very few sample directly from umbilical arteries. Almost all studies measure total T rather than free (unbound) T.
Some papers on this topic (Mathur et al., 1980; Bolton et al., 1989; Pardo et al., 1993; Troisi et al., 2003; Anderson et al., 2010) speculate or infer that umbilical arterial T is of fetal origin and umbilical vein T is of maternal/placental origin. This hypothesis has not been proved, but if male fetuses produce more T than females, and if the umbilical arteries carry hormones of fetal origin, then the umbilical arteries of males should contain more T than the arteries of females (i.e. a sex difference in arterial T). By extension, because mixed cord T contains arterial T, mixed cord T should show a larger sex difference than the sex difference for venous T.
arteries". This retrieved 52, 26, and 16 publications respectively, all of which were previously found using the Pubmed keyword search. The Cochrane Reviews database produced six publications, but these were not relevant. A hand search of relevant articles referenced in these publications were obtained, which produced nine publications not previously found. Each article was assessed by [authors 1 and 4] , and articles that fitted the main criteria (assaying T in umbilical cord vein in healthy pregnancies) were accessed.
Methodological quality was assessed based on the criteria of the Scottish Intercollegiate Guidelines Network (2010).
Inclusion and exclusion criteria
Human studies that compared male and female umbilical cord total T at birth were eligible for inclusion provided that: a. The pregnancies were healthy b. The deliveries were spontaneous, or else planned caesarean sections c. The assay methods were IA, CLIA/ECL, a method using extraction, or mass spectrometry.
Papers with titles or abstracts that indicated that they were not relevant (for various reasons e.g. reviews, single case studies etc) were excluded. A literature search flow chart (S1), an additional Forest plot (S2), Table 1 shows the characteristics of the included studies.
[ Table I . here]
Of the included studies, six used direct methods (five IA and one CLIA/ECL), eleven used extraction methods (9 with thin layer chromatography and two with di-ethyl ether extraction alone), and one used LCMS. There were no mixed cord X-IA studies, and only one direct assay mixed cord study.
Two studies (Dawood & Saxena, 1977; Bolton et al., 1989) measured T in umbilical arteries and vein separately. The venous samples for these two studies were included in the venous subgroup, and the means of their arterial and venous samples combined were included in the mixed cord subgroup.
Only the venous samples for these two studies were included in the 'all groups' analysis. Two studies used 'predominantly' (Abramovich, 1974) or 'mainly' (Maccoby et al., 1979) venous blood, so were classified as venous. One study did not state whether they differentiated between arteries and vein (Gol et al., 2004) and was classified as 'mixed'. Thirteen of the studies were classified as being of moderate quality, four were classified as poor (Forest et al., 1973; Abramovich, 1974; Dawood & Saxena, 1977; Shinkawa et al., 1983) and one classified as good (Troisi et al., 2003) .
Statistical analysis
Statistical analyses were performed using Review Manager, Version 5 (RevMan 5). Heterogeneity tests suggested that a random effects model was appropriate to assess the sex difference in umbilical vein T levels in seven of the eight subgroups and the studies as a whole. The I² value in the direct assay subgroup was zero thus suggesting no problem with heterogeneity, but in the interests of not risking an underestimation of the heterogeneity between studies the more conservative random effects model was used rather than fixed effects. The inverse variance method was used. The effect size was measured as the standard mean difference, calculated using Hedges' g. By convention, like Cohen's d the thresholds for small, moderate and large Hedges' g effect sizes are 0.2, 0.5, and 0.8 respectively. All T values are presented in nmol/l, and were converted from other units for most studies.
Results
Seventy studies of umbilical cord T were retrieved from the electronic databases. Eighteen studies using 1229 samples (602 male and 627 female) qualified for review according to the inclusion criteria. 834 samples were venous (410 male and 424 female), 395 were mixed (192 male and 203 female), and 41 were arterial (Bolton et al., 1989) , (Dawood & Saxena, 1977 ) (21 male and 20 female). Fifty-two trials were excluded. Table II shows cord T levels (nmol/l) for the included studies. It can be seen that most studies (16 of 18) found higher cord T in boys than girls, and that overall this difference was of a moderate effect size (Hedges' g = .57).
[ Table II . here] Table III shows the results of meta-analyses. Although there was a lot of heterogeneity in the findings (evidenced by the large I² values) the various groups based on assay types and sources of serum all indicate significantly higher T in male umbilical cord than female.
[ Table III . here] Figure 
Discussion
Analysis of all eighteen studies combined, and all subgroups, revealed significantly higher umbilical cord T in boys than girls. There was significant heterogeneity between the 18 studies and in all subgroups except for the direct assay venous subgroup. The confidence intervals for the subgroups were generally narrow and showed effect sizes of clinical interest. With the exception of the venous chromatographic extraction subgroup the confidence intervals did not encompass a zero value, which suggests that overall the sex differences were representative of those likely to be seen in the general population of newborns. Four of the 18 studies were rated as poor, largely due to these papers lacking information regarding methodological quality rather than explicitly being of poor quality. The four 'poor' ratings were on the borderline for scores for moderate quality and excluding them from the overall analysis made almost no difference to the results, thus their inclusion is appropriate.
The most widely available assay methods, in descending order of accuracy, use mass spectrometry, thin layer chromatography (TLC), extraction with ethyl ether, and direct measurement (Rosner et al., 2007) . A therefore unexpected finding of this meta-analysis is that, judging by heterogeneity measures, the direct method may be a more reliable indicator than extraction methods of the sex difference in cord T.
However it is likely that the direct method assay detected more substances than T alone, and the interference of other steroids and substances may have simply masked the heterogeneity evidenced in the extraction group. The cross-reacting substances are most likely to have been androgens such as 11-keto-testosterone, 11-beta-OH-testosterone, and dihydrotestosterone (Roche Diagnostics, 2000) ; for this reason the direct assay might be viewed as an omnibus measure of androgens rather than simply a measure of T. This interpretation remains to be confirmed by a superior assay method, though it is of interest that Legro et al (2010) recently found good correlations between T levels measured using a direct assay and using liquid chromatography mass spectrometry in women with PCOS. Only one study to date (Anderson et al., 2010) has measured T levels in umbilical cord samples using liquid chromatography mass spectrometry.
Anderson et al found that 14 healthy girls had nonsignificantly higher mixed cord T than seven healthy boys (0.66+1.01 vs 0.49+0.35 nmol/l). Sixty-six percent of these samples (10 of the 14 female and four of the seven male) had T levels lower than the detection limit of 0.24 nmol/l. These samples were assigned a value of 0.24 nmol/l. The fact that the actual T level is unknown for 66% of these samples indicates that more sensitive mass spectrometry assays are needed.
Two of the 18 studies (11% of the studies) found that girls had higher cord T than boys, and across studies the large amount of variation in the observed T levels gives cause for concern. Rosner et al. (2007) found that some of their direct assays of T in healthy women were roughly 10 times higher than others; the present authors found that two studies (Gol et al., 2004) , (Furuhashi, 1982) reported T values over 100 times higher than some other studies using comparable assays and sample sites. These studies were of moderate methodological quality, and the disparity is not explained by other features of the studies. Although the Hedges g values of the two studies are in keeping with the other sixteen studies, their relatively high observed T values are suggestive of the unreliability of these assay types. With the exception of one study (Furuhashi, 1982) , the extraction methods showed generally lower mean T values with a smaller range than the direct assay studies. Because the studies included in this meta-analysis are similar in most relevant characteristics, it might be concluded that although the direct assays give reliable findings in terms of the size of the sex difference, no method appears to yield reliable findings in terms of the absolute T levels, especially the direct immunoassay due to its poor specificity, cross reactivity with other steroids and matrix effects (Rosner et al., 2007) .
A finding of potential clinical importance is that, using comparable assays, a larger sex difference was seen in mixed cord samples (g = .94, a large effect size) than venous samples (g = .32, a small effect size). This in turn would suggest that the higher level in males is due at least part to fetal production.
This has implications for understanding the etiology of conditions such as PCOS in which prenatal T exposure is theorised to be a causal factor. Future studies might compare T levels in the umbilical arteries and veins in newborns of women with PCOS, and compare these to healthy pregnancies; relatively high T in the umbilical arteries compared to the vein in PCOS, and higher umbilical arterial T in PCOS compared to healthy pregnancies, would suggest fetal T production in this condition. A recent study of PCOS and metformin -a medication that lowers T -had the potential to address this issue, but interpretation of the findings is difficult because the results were not presented for girls whose mothers had PCOS and were not taking metformin (Carlsen & Vanky, 2010) The conclusion of this meta-analysis is that although there appears to be a reliable sex difference in umbilical vein T of a moderate effect size, the direct and extraction assay methods lack ecological validity; differences in steroid milieu outside that usually used for in vitro diagnostic purposes produce wide differences in results where such assays are employed to measure specific steroids in real-world samples.
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